← Back to patent-cliff list
Gamma-Tocotrienol
Tier C — Watch / tradeGamma-Tocotrienol
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Natural product / extract
Type
Targets：Not applicable
Indications (approved)：Obesity, Menopausal symptoms, Hypercholesterolaemia
Regional status
US
Phase II
2019-03-15
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Gamma-Tocotrienol?
Approved indications include: Obesity, Menopausal symptoms, Hypercholesterolaemia.
When does the Gamma-Tocotrienol patent expire?
No public expiry year is available for Gamma-Tocotrienol yet; this page updates once verified.
How do I get a quote for Gamma-Tocotrienol intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-08